Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03591263
Other study ID # 201805017RINB
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 25, 2018
Est. completion date June 25, 2024

Study information

Verified date April 2023
Source National Taiwan University Hospital
Contact Ping-Lun Hsieh
Phone +886-905925933
Email 107673@ntuh.gov.tw
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Chronic obstructive pulmonary disease is a chronic inflammatory lung disease that causes obstructed airflow from the lung, characterized by chronic cough, dyspnea, and sputum production, which often misunderstood as aging or catching a cold. These symptoms may be progressive over time. To provide better disease management and early detecting, pulmonary rehabilitation is now considered a fundamental component of the integrated disease management of this population. However, few studies have evaluated the beneficial outcomes in patients referred to pulmonary rehabilitation. Therefore, the purpose of this study is to investigate the clinical outcomes in patients referred to pulmonary rehabilitation in National Taiwan University Hospital.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date June 25, 2024
Est. primary completion date June 25, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion criteria: 1. age > 20 years old 2. patients with chronic respiratory disease diagnosed by physician that referred to pulmonary rehabilitation in National Taiwan University Hospital including, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, bronchiectasis 3. can cooperate with pulmonary rehabilitation clinic Exclusion criteria: 1. angina, acute myocardial infarction in the previous one month 2. pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pulmonary rehabilitation
Pulmonary rehabilitation as routine care includes, airway clearance techniques, breathing exercise, and physical training instruction

Locations

Country Name City State
Taiwan Physical Therapy Center at National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functional exercise capacity using the six-minute walk test The six-minute walk test is commonly performed to evaluate functional exercise capacity. The six-minute walk test was performed according to the guidelines, and the distance walked in the test presented as functional exercise capacity. The six-minute walk test needs six minute to complete the test
Primary Muscle strength: hand grip Hand grip strength is performed by using hand dynamometer Hand grip of both hands need about three minutes to complete
Primary Lung hygiene Lung hygiene is evaluated by the frequency of acute exacerbation Lung hygiene is evaluated as the frequency of acute exacerbation in the the past one year
Primary Home-based physical activity All subjects were encouraged to increase their daily physical activity and recorded the amount of physical activity on patient-self-record training log. Record the home-based physical activities everyday that the subjects have in the past one week that lasting for one year.
Primary Muscle strength: leg press Maximum leg press is performed by using seated leg press machine Maximum leg press measurement needs about four minutes to complete
Primary Heart rate Heart rate is measured at rest, during hospital-based physical training. Hospital-based physical training takes 30 minutes, once a week, and it also takes 30 min to measure continuously
Primary Blood pressure systolic and diastolic pressure are measured at rest, during hospital-based physical training. Hospital-based physical training takes 30 minutes, once a week, and it also takes 30 min to measure continuously
Primary Perceived dyspnea Rating of perceived dyspnea is measured by using Borg scale at rest, during hospital-based physical training, and home-based physical activity. The most widely used tool is the "Borg scale", with rating ranges from 0 (nothing at all) to 10 (extremely dyspnea). It takes less than one minute to evaluate perceived dyspnea.
Primary Oxygen saturation Oxygen saturation is continuously monitored by pulse oximetry throughout Hospital-based physical training. Hospital-based physical training takes 30 minutes, once a week, and it also takes 30 min to measure continuously
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy